Further, while we chose SK-MEL-5 cells as a representative of melanoma cells due to their BRAF mutation and cellular morphology, a difference between this cell line and other established lines is that the donor was significantly younger (24 years old) and has a CDKN2A mutation [87]. This evidence concerns the gene CDKN2A and melanoma.